loading
Precedente Chiudi:
$123.02
Aprire:
$131.54
Volume 24 ore:
190.25K
Relative Volume:
0.42
Capitalizzazione di mercato:
$70.38M
Reddito:
$7.10M
Utile/perdita netta:
$-39.43M
Rapporto P/E:
-131.38
EPS:
-0.94
Flusso di cassa netto:
$-46.50M
1 W Prestazione:
-4.78%
1M Prestazione:
+1,492%
6M Prestazione:
-86.69%
1 anno Prestazione:
-90.34%
Intervallo 1D:
Value
$118.10
$131.54
Intervallo di 1 settimana:
Value
$112.95
$144.00
Portata 52W:
Value
$7.26
$543.38

Spruce Biosciences Inc Stock (SPRB) Company Profile

Name
Nome
Spruce Biosciences Inc
Name
Telefono
(415) 655-4168
Name
Indirizzo
611 GATEWAY BOULEVARD, SUITE 740, SOUTH SAN FRANCISCO
Name
Dipendente
20
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
SPRB's Discussions on Twitter

Confronta SPRB con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SPRB
Spruce Biosciences Inc
125.00 69.32M 7.10M -39.43M -46.50M -0.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.15 107.73B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
650.67 62.04B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
480.00 62.73B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
834.79 51.09B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.03 34.67B 398.11M -1.03B -868.57M -5.7032

Spruce Biosciences Inc Stock (SPRB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-11 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2024-12-11 Downgrade Oppenheimer Outperform → Perform
2024-03-14 Downgrade Guggenheim Buy → Neutral
2024-03-14 Downgrade H.C. Wainwright Buy → Neutral
2024-03-14 Downgrade Ladenburg Thalmann Buy → Neutral
2024-03-14 Downgrade Leerink Partners Outperform → Market Perform
2024-03-14 Downgrade RBC Capital Mkts Outperform → Sector Perform
2024-02-21 Iniziato Guggenheim Buy
2021-12-17 Iniziato Oppenheimer Outperform
2021-12-10 Iniziato The Benchmark Company Speculative Buy
2021-11-16 Downgrade SVB Leerink Outperform → Mkt Perform
2021-07-19 Iniziato H.C. Wainwright Buy
2021-04-26 Ripresa Credit Suisse Outperform
2020-11-03 Iniziato Cowen Outperform
2020-11-03 Iniziato Credit Suisse Outperform
2020-11-03 Iniziato RBC Capital Mkts Outperform
2020-11-03 Iniziato SVB Leerink Outperform
Mostra tutto

Spruce Biosciences Inc Borsa (SPRB) Ultime notizie

pulisher
10:25 AM

SPRB: JMP Securities Upgrades Spruce Biosciences to Market Outpe - GuruFocus

10:25 AM
pulisher
05:01 AM

Spruce Biosciences stock upgraded by Citizens on promising MPS IIIB therapy - Investing.com Nigeria

05:01 AM
pulisher
Oct 24, 2025

Levi & Korsinsky Reminds Spruce Biosciences Investors of the Ongoing Investigation into Potential Violations of Securities LawsSPRB - ACCESS Newswire

Oct 24, 2025
pulisher
Oct 22, 2025

Spruce Biosciences CFO vests 2,053 RSUs; owns 6,066 shares - Stock Titan

Oct 22, 2025
pulisher
Oct 22, 2025

SPRB insider filing: CEO nets 3,245 shares after RSU vest - Stock Titan

Oct 22, 2025
pulisher
Oct 22, 2025

The science behind the therapy that catapulted a biopharma’s stock 1,400% and counting - healthcare-brew.com

Oct 22, 2025
pulisher
Oct 22, 2025

Leerink Partners Maintains Spruce Biosciences (SPRB) Market Perform Recommendation - Nasdaq

Oct 22, 2025
pulisher
Oct 21, 2025

Spruce Biosciences (SPRB): Analyst Raises Price Target Significa - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Spruce Biosciences stock price target raised to $160 from $10 at Leerink - Investing.com Philippines

Oct 21, 2025
pulisher
Oct 20, 2025

Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough – Inside the Stock Surge, Pipeline & Outlook (Oct 2025) - ts2.tech

Oct 20, 2025
pulisher
Oct 20, 2025

Mintz Advises the Placement Agents in Spruce Biosciences, Inc.’s $50 Million Private Placement - Mintz

Oct 20, 2025
pulisher
Oct 19, 2025

Spruce Biosciences (SPRB) Skyrockets 1,300% on FDA Breakthrough News – Experts Weigh In - ts2.tech

Oct 19, 2025
pulisher
Oct 19, 2025

Spruce Biosciences (NASDAQ:SPRB) Upgraded at Zacks Research - Defense World

Oct 19, 2025
pulisher
Oct 18, 2025

SPRUCE BIOSCIENCES, INC. trading resumes - MSN

Oct 18, 2025
pulisher
Oct 17, 2025

SPRB director steps down; company notes no disagreement - Stock Titan

Oct 17, 2025
pulisher
Oct 17, 2025

Spruce Biosciences, Inc. Announces Resignation of Bali Muralidhar as Member of Board of Directors and as Member of the Compensation Committee of the Board, Effective October 15, 2025 - MarketScreener

Oct 17, 2025
pulisher
Oct 16, 2025

Spruce Biosciences Stock More Than Quadruples After Breakthrough Therapy Designation To Therapy For Rare And Fatal Genetic Disease - MSN

Oct 16, 2025
pulisher
Oct 16, 2025

Head to Head Contrast: PyroGenesis Canada (NASDAQ:PYRGF) vs. Spruce Biosciences (NASDAQ:SPRB) - Defense World

Oct 16, 2025
pulisher
Oct 15, 2025

What Makes Spruce Biosciences, Inc. (SPRB) a Strong Momentum Stock: Buy Now? - sharewise.com

Oct 15, 2025
pulisher
Oct 15, 2025

Spruce Biosciences’ (SPRB) “Sell (D-)” Rating Reaffirmed at Weiss Ratings - Defense World

Oct 15, 2025
pulisher
Oct 15, 2025

Spruce Biosciences insider filing shows 256-share buy, 1,050 held - Stock Titan

Oct 15, 2025
pulisher
Oct 14, 2025

Spruce Biosciences to sell 502,181 shares at $68.00 in private placement - MSN

Oct 14, 2025
pulisher
Oct 11, 2025

Spruce Biosciences (NASDAQ:SPRB) Shares Down 1% – What’s Next? - Defense World

Oct 11, 2025
pulisher
Oct 11, 2025

Spruce Biosciences (NASDAQ:SPRB) Shares Down 1%What's Next? - MarketBeat

Oct 11, 2025
pulisher
Oct 09, 2025

Medical Stocks To ConsiderOctober 6th - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Promising Pharmaceutical Stocks Worth WatchingOctober 6th - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

Parkman healthcare sells Spruce Biosciences (SPRB) shares for $4920 By Investing.com - Investing.com UK

Oct 09, 2025
pulisher
Oct 08, 2025

Spruce Biosciences, Inc. announced that it has received $49.999769 million in funding - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Parkman healthcare sells Spruce Biosciences (SPRB) shares for $4920 - Investing.com India

Oct 08, 2025
pulisher
Oct 08, 2025

SPRUCE BIOSCIENCES, INC. trading halted, volatility trading pause - MSN

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences announces $50M private placement financing - TipRanks

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences (SPRB) Secures $50M for Therapy Advancements - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Three Biotech Stocks Jump After Big Regulatory Wins - Finimize

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences (SPRB) Secures $50M for Enzyme Replacement Th - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences to Raise $50 Million Through Private Placement; Shares Down Pre-Bell - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences (SPRB) Secures $50 Million for Enzyme Therapy Development - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences secures $50 million in private placement By Investing.com - Investing.com Canada

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences secures $50 million in private placement - Investing.com

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences (SPRB) Secures $50M in Private Placement for Therapy Advancement - GuruFocus

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Bio jumps after breakthrough therapy status for enzyme replacement therapy - MSN

Oct 08, 2025
pulisher
Oct 08, 2025

Spruce Biosciences announces $50.0 million private placement financing - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

ContactThe Lethbridge HeraldNews and Sports from around Lethbridge - FinancialContent

Oct 08, 2025
pulisher
Oct 08, 2025

Small Cap Stocks To Follow Today – October 6th - Defense World

Oct 08, 2025
pulisher
Oct 08, 2025

Understanding the Current Trends in SPRB Stock - Info Petite Nation

Oct 08, 2025
pulisher
Oct 08, 2025

Medical Stocks To Consider – October 6th - Defense World

Oct 08, 2025
pulisher
Oct 07, 2025

Biotech And Tech Stocks Rally On Breakthrough News And Partnerships - Finimize

Oct 07, 2025
pulisher
Oct 07, 2025

Spruce Biosciences Stock: Emergent Surges and Market Implications - timothysykes.com

Oct 07, 2025
pulisher
Oct 07, 2025

SPRB Stock Hits 19-Month High Amid Trading Halts - NewsBreak: Local News & Alerts

Oct 07, 2025
pulisher
Oct 07, 2025

Spruce Biosciences’ Breakthrough: Stock Skyrockets - StocksToTrade

Oct 07, 2025
pulisher
Oct 07, 2025

Spruce Biosciences Soars: What’s Driving the Surge? - timothysykes.com

Oct 07, 2025

Spruce Biosciences Inc Azioni (SPRB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Spruce Biosciences Inc Azioni (SPRB) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Szwarcberg Javier B.
CHIEF EXECUTIVE OFFICER
Oct 20 '25
Option Exercise
0.00
4,784
0
11,013
Parkman Healthcare Partners LL
10% Owner
Oct 06 '25
Buy
17.91
256
4,585
1,307
Parkman Healthcare Partners LL
10% Owner
Oct 06 '25
Sale
19.14
257
4,920
1,050
Parkman Healthcare Partners LL
10% Owner
Oct 06 '25
Buy
17.91
256
4,585
1,307
Parkman Healthcare Partners LL
10% Owner
Oct 06 '25
Sale
19.14
257
4,920
1,050
$36.38
price down icon 2.38%
$92.03
price down icon 1.25%
$29.11
price up icon 0.34%
$105.73
price down icon 0.38%
biotechnology ONC
$317.24
price up icon 0.46%
$164.69
price up icon 0.31%
Capitalizzazione:     |  Volume (24 ore):